These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17120196)
1. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid. Zhang H; Wu Y; Malewicz B; Lu J; Li S; Marshall J; Ip C; Dong Y Cancer; 2006 Dec; 107(12):2942-8. PubMed ID: 17120196 [TBL] [Abstract][Full Text] [Related]
2. Telomerase as an important target of androgen signaling blockade for prostate cancer treatment. Liu S; Qi Y; Ge Y; Duplessis T; Rowan BG; Ip C; Cheng H; Rennie PS; Horikawa I; Lustig AJ; Yu Q; Zhang H; Dong Y Mol Cancer Ther; 2010 Jul; 9(7):2016-25. PubMed ID: 20571066 [TBL] [Abstract][Full Text] [Related]
3. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
4. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Zhao H; Whitfield ML; Xu T; Botstein D; Brooks JD Mol Biol Cell; 2004 Feb; 15(2):506-19. PubMed ID: 14617803 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Dong Y; Zhang H; Gao AC; Marshall JR; Ip C Mol Cancer Ther; 2005 Jul; 4(7):1047-55. PubMed ID: 16020662 [TBL] [Abstract][Full Text] [Related]
6. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
7. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
8. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor. Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097 [TBL] [Abstract][Full Text] [Related]
9. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. Yan J; Xie B; Capodice JL; Katz AE Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835 [TBL] [Abstract][Full Text] [Related]
10. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. Kai L; Levenson AS Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524 [TBL] [Abstract][Full Text] [Related]
12. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Zhang Y; Ni J; Messing EM; Chang E; Yang CR; Yeh S Proc Natl Acad Sci U S A; 2002 May; 99(11):7408-13. PubMed ID: 12032296 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action. Husbeck B; Bhattacharyya RS; Feldman D; Knox SJ Mol Cancer Ther; 2006 Aug; 5(8):2078-85. PubMed ID: 16928829 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469 [TBL] [Abstract][Full Text] [Related]
15. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth. Mashima T; Okabe S; Seimiya H Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811 [TBL] [Abstract][Full Text] [Related]
17. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells. Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080 [TBL] [Abstract][Full Text] [Related]
18. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Dong Y; Lee SO; Zhang H; Marshall J; Gao AC; Ip C Cancer Res; 2004 Jan; 64(1):19-22. PubMed ID: 14729601 [TBL] [Abstract][Full Text] [Related]
19. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018 [TBL] [Abstract][Full Text] [Related]